InMed Pharmaceuticals Inc. Share Price
NASDAQ: INM | Micro CapInMed Pharmaceuticals Inc. Stock Performance
Open $1.48 | Prev. Close $1.46 | Circuit Range N/A |
Day Range $1.42 - $1.48 | Year Range $0.60 - $2.46 | Volume 2,569 |
Average Traded $1.44 |
InMed Pharmaceuticals Inc. Share Price Today
As of 10 August 2026, InMed Pharmaceuticals Inc.'s share price is $1.47. The stock opened at $1.48, compared to its previous close of $1.46. During today's trading session, InMed Pharmaceuticals Inc.'s share price traded between $1.42 and $1.48, with an average price of $1.45. Over the past 52 weeks, the stock has recorded a high of $2.46 and a low of $0.60. In terms of performance, InMed Pharmaceuticals Inc.'s share price has risen by 67.05% over the last six months and is down 33.48% on a year-on-year basis.
InMed Pharmaceuticals Inc. Share Price Chart
InMed Pharmaceuticals Inc. Stock Fundamentals & Key Indicators
Market Cap $11.20M | PE Ratio (TTM) -1.46 | Dividend Yield N/A |
EPS (TTM) $-1.01 | Revenue (TTM) $4.60M | Return On Equity (TTM) -83.37% |
Profit Margin -166.94% | Debt to Equity 0.21 | Quarterly Earnings Growth YoY 21.23% |
InMed Pharmaceuticals Inc. Quarterly Profit & Loss
All figures in USD
InMed Pharmaceuticals Inc. Annual Profit & Loss
All figures in USD
About InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. It operates through two segments: InMed Pharma and BayMedica Commercial. The InMed Pharma segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with high unmet medical needs. The company's lead product is INM-755, a cannabinol topical skin cream, completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-089, which is a small molecule compound acting as a selective dual CB1 /CB2 agonist; and INM-900 for neurodegenerative diseases. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach, for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
InMed Pharmaceuticals Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.47 | $1.47 | +0.00% |
Jul 2026 | $1.55 | $1.47 | -6.37% |
Jun 2026 | $1.56 | $1.57 | -0.95% |
May 2026 | $0.77 | $1.58 | +115.94% |
Apr 2026 | $0.65 | $0.73 | +13.80% |
Mar 2026 | $0.83 | $0.65 | -26.70% |
Feb 2026 | $1.11 | $0.88 | -19.27% |
Jan 2026 | $1.09 | $1.09 | +0.93% |
Dec 2025 | $1.29 | $1.08 | -19.10% |
Nov 2025 | $1.86 | $1.33 | -28.61% |
Oct 2025 | $2.17 | $1.87 | -15.77% |
Sep 2025 | $2.17 | $2.22 | +0.45% |
INM Share Price FAQs
What is InMed Pharmaceuticals Inc. share price today?
What is the 52 week high and 52 week low of InMed Pharmaceuticals Inc. stock?
What is INM's market capitalisation today?
What is INM's net income for the last quarter?
What is the 5 year returns of INM?
What is the high & low stock price of INM today?
Can I buy INM shares in India?